1Suppliers
0Customers
3Debt Items
0Related Chains
Telomir Pharmaceuticals, Inc. Suppliers
| Ticker | Name | Confidence | Evidence |
| BAYSHORE-TRUST |
BAYSHORE-TRUST |
90%
|
As a condition to closing, Bayshore Trust, a shareholder of TELI, contributed $1 million at closing to the Company |
Telomir Pharmaceuticals, Inc. Customers
No clients on recordNo downstream customers found in our database for Telomir Pharmaceuticals, Inc..
Telomir Pharmaceuticals, Inc. Debt Obligations
| Instrument | Description | Confidence | Evidence |
| TELO-DEBT-12935 |
Warrants outstanding: 7 |
90%
|
xbrl warrant detail from xbrl 2024-12-31. |
| TELO-DEBT |
Debt stack $202,869 |
90%
|
Market cache reports total debt of $202,869. |
| TELO-DEBT-12936 |
Xbrl Convertible |
90%
|
xbrl convertible detail from xbrl 2023-12-31. |
Telomir Pharmaceuticals, Inc. Acquisitions
| Acquired Entity | Name | Confidence | Evidence |
| TELO-ACQ-0001493152-26-018867 |
Telomir Pharmaceuticals, Inc. issued 34,389,710 restricted shares to acquire TELI Pharmaceutical... |
85%
|
Telomir Pharmaceuticals, Inc. issued 34,389,710 restricted shares to acquire TELI Pharmaceuticals, Inc. |
Telomir Pharmaceuticals, Inc. Ownership
| Holder | Name | Confidence | Evidence |
| TELO-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC |
VANGUARD CAPITAL MANAGEMENT LLC |
90%
|
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 30 tracked holders. |
Telomir Pharmaceuticals, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.